- Home
- VMD vs AMRN Comparison
VMD vs AMRN Comparison
Compare VMD & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VMD | AMRN |
|---|---|---|
| Founded | 2006 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.2M | 336.1M |
| IPO Year | 2018 | 1998 |
Fundamental Metrics
Financial Performance| Metric | VMD | AMRN |
|---|---|---|
| Price | $11.46 | $16.41 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 224.6K | 90.7K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.14 | ★ 55.00 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $270,280,000.00 | $181,104,000.00 |
| Revenue This Year | $17.88 | N/A |
| Revenue Next Year | $14.98 | $1.26 |
| P/E Ratio | $182.33 | ★ N/A |
| Revenue Growth | 20.52 | ★ 39.22 |
| 52 Week Low | $5.93 | $12.96 |
| 52 Week High | $11.04 | $20.90 |
Technical Indicators
Market Signals| Indicator | VMD | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 77.60 | 69.52 |
| Support Level | $9.26 | $13.58 |
| Resistance Level | N/A | $17.00 |
| Average True Range (ATR) | 0.35 | 0.84 |
| MACD | 0.11 | 0.17 |
| Stochastic Oscillator | 94.00 | 75.21 |
Price Performance
Historical ComparisonAbout VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.